Teemu Niiranen
MD, PhD
tejuni@utu.fi |
Cardiovascular epidemiology; cohort studies; blood pressure; hypertension; blood pressure measurement
Teemu Niiranen, MD, PhD, is a physician-scientist and a clinical hypertension specialist with a track record of productivity in hypertension research, successful mentoring, international research grant procurement, and inter-institutional international collaborations. His research on hypertension in large population cohorts has led to >250 publications that are cited by the European, American, British, and Japanese clinical hypertension guidelines. These publications include first- or last-author articles in BMJ, Circulation, European Heart Journal, Nature Communications and JAMA Cardiology.
After finishing his PhD and clinical training, Dr. Niiranen received in-depth training in cardiovascular disease epidemiology and omics during a post-doctoral period at the Framingham Heart Study, the oldest and most prestigious cardiovascular cohort study in the world. After his post-doctoral period, he was selected as one of the new Group Leaders of the University of Turku Collegium of Science and Medicine and in 2020, the professor of internal medicine at the university. He is also employed as a Medical Specialist by the National Institute for Health and Welfare and chairs the work of the Cardiometabolic Clinical Expert Group of the FinnGen study, a project that has genotyped up to 500 000 unique Finnish blood samples and merged this genetic data with nationwide healthcare registers.
Dr. Niiranen has received young investigator awards from the American and Finnish Societies of Hypertension, and the American Heart Association. He is the past chair of the Finnish Hypertension Society and has mentored 12 PhD students. He is a co-author of the Finnish and European Society of Hypertension clinical hypertension guidelines.
In addition to general cardiovascular epidemiology, Dr. Niiranen's research has focused on the epidemiology of hypertension in large scale population cohorts. His studies particularly focused on home monitoring of blood pressure and more recently he has moved into examining the relation between hypertension and omics (genome, metagenome and metabolome).
Hypertension and clinical epidemioogy.
- Targeting Gut Microbiota to Treat Hypertension: A Systematic Review (2021)
- International Journal of Environmental Research and Public Health
- Tasapainoilu verenpaineen hoidon ja ortostaattisen hypotension välillä (2021)
- Duodecim
- Taxonomic signatures of cause-specific mortality risk in human gut microbiome (2021)
- Nature Communications
- The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study (2021)
- BMC Cardiovascular Disorders
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021)
- Lancet
- 24-h urinary sodium excretion and the risk of adverse outcomes (2020)
- Annals of Medicine
- Age of Hypertension Onset: Overview of Research and How to Apply in Practice (2020)
- Current Hypertension Reports
- An Early-Onset Subgroup of Type 2 Diabetes: A Multigenerational, Prospective Analysis in the Framingham Heart Study (2020)
- Diabetes Care
- An instrument for measuring blood pressure and assessing cardiovascular health from the fingertip (2020)
- Biosensors and Bioelectronics
- A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling (2020)
- American Journal of Human Genetics
- Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort (2020)
- EP-Europace
- Association between self-reported hypertension onset age and electrocardiographic left ventricular hypertrophy (2020)
- Journal of Human Hypertension
- Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals (2020)
- Journal of the American Heart Association
- Cardiac Troponin I and Incident Stroke in European Cohorts Insights From the BiomarCaRE Project (2020)
- Stroke
- Cardiometabolic risk-related blood pressure trajectories differ by sex (2020)
- Hypertension
- Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components (2020)
- Hypertension
- Clinical practice patterns in revascularization of diabetic patients with coronary heart disease: nationwide register study (2020)
- Annals of Medicine
- Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults (2020)
- Journal of the American Heart Association
- Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death (2020)
- Journal of the American Heart Association
- Diagnostic Value of Home Blood Pressure (2020) Home Blood Pressure Monitoring Kazuomi Kario, Yutaka Imai, Anastasios Kollias, Teemu J. Niiranen, Takayoshi Ohkubo, Richard J. McManus, George S. Stergiou